both sessions which are planned for today will start (08:15 PDT)....
Session: Diagnosis and Treatment of Nontuberculous Mycobacteria Infections
Title: A Randomized, Double-Blind, Placebo-Controlled Study of Liposomal Amikacin for Inhalation (Arikayce) in Patients with Recalcitrant Nontuberculous Mycobacterial Lung Disease
Session: Late-Breaking Abstracts in Disease Treatment and Clinical Outcomes
Title: Clinical Benefit of Liposomal Amikacin for Inhalation as Assessed by the Cystic Fibrosis Questionnaire-Revised